BioInvent International AB
STO:BINV
BioInvent International AB
Research & Development
BioInvent International AB
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioInvent International AB
STO:BINV
|
Research & Development
-kr504.2m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-20%
|
|
|
Biogaia AB
STO:BIOG B
|
Research & Development
-kr115.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Research & Development
-kr91.4m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Research & Development
-kr109m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Research & Development
-kr3.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-20%
|
|
|
BioArctic AB
STO:BIOA B
|
Research & Development
-kr376.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioInvent International AB
Glance View
BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
See Also
What is BioInvent International AB's Research & Development?
Research & Development
-504.2m
SEK
Based on the financial report for Dec 31, 2025, BioInvent International AB's Research & Development amounts to -504.2m SEK.
What is BioInvent International AB's Research & Development growth rate?
Research & Development CAGR 10Y
-20%
Over the last year, the Research & Development growth was -15%. The average annual Research & Development growth rates for BioInvent International AB have been -17% over the past three years , -23% over the past five years , and -20% over the past ten years .
